These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients. Zhuang Z; Bai Q; A L; Liang Y; Zheng D; Wang Y Int J Clin Exp Pathol; 2015; 8(9):11464-9. PubMed ID: 26617876 [TBL] [Abstract][Full Text] [Related]
6. Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats. Fan YY; Kobori H; Nakano D; Hitomi H; Mori H; Masaki T; Sun YX; Zhi N; Zhang L; Huang W; Zhu B; Li P; Nishiyama A Horm Metab Res; 2013 May; 45(5):338-43. PubMed ID: 23322513 [TBL] [Abstract][Full Text] [Related]
7. Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. Kamiyama M; Zsombok A; Kobori H J Pharmacol Sci; 2012; 119(4):314-23. PubMed ID: 22850612 [TBL] [Abstract][Full Text] [Related]
8. [Up-regulation of intrarenal renin-angiotensin system contributes to renal damage in high-salt induced hypertension rats]. Wu HY; Liang YX; Bai Q; Zhuang Z; A LT; Zheng DX; Wang Y Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 47(1):149-54. PubMed ID: 25686347 [TBL] [Abstract][Full Text] [Related]
9. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus. Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444 [TBL] [Abstract][Full Text] [Related]
10. Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus. Woods TC; Satou R; Miyata K; Katsurada A; Dugas CM; Klingenberg NC; Fonseca VA; Navar LG Am J Nephrol; 2019; 49(4):331-342. PubMed ID: 30921791 [TBL] [Abstract][Full Text] [Related]
11. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients. Xu Z; Xu B; Xu C Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631 [TBL] [Abstract][Full Text] [Related]
12. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Urushihara M; Nagai T; Kinoshita Y; Nishiyama S; Suga K; Ozaki N; Jamba A; Kondo S; Kobori H; Kagami S Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477 [TBL] [Abstract][Full Text] [Related]
13. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients. Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527 [TBL] [Abstract][Full Text] [Related]
14. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation. Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851 [TBL] [Abstract][Full Text] [Related]
15. Urinary angiotensinogen level is increased in renal transplant recipients with masked hypertension and is correlated with left ventricular mass index and albuminuria in these patients. Tiryaki O; Usalan C; Kul S; Tarakcioglu M; Sucu M; Yildiz F; Coban S Clin Transplant; 2018 Sep; 32(9):e13375. PubMed ID: 30080282 [TBL] [Abstract][Full Text] [Related]
16. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight. Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100 [TBL] [Abstract][Full Text] [Related]
17. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury. Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346 [TBL] [Abstract][Full Text] [Related]
18. Role of stimulated intrarenal angiotensinogen in hypertension. Satou R; Shao W; Navar LG Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):181-90. PubMed ID: 25987608 [TBL] [Abstract][Full Text] [Related]
19. An evaluation of renin-angiotensin system markers in youth with type 2 diabetes and associations with renal outcomes. Dart AB; Wicklow B; Scholey J; Sellers EA; Dyck J; Mahmud F; Sochett E; Hamilton J; Blydt-Hansen T; Burns K Pediatr Diabetes; 2020 Nov; 21(7):1102-1109. PubMed ID: 32657529 [TBL] [Abstract][Full Text] [Related]